Literature DB >> 25911290

Chronic villitis of unknown etiology and massive chronic intervillositis have similar immune cell composition.

C A Labarrere1, J W Hardin2, D M Haas3, G S Kassab4.   

Abstract

INTRODUCTION: Chronic villitis of unknown etiology (CVUE) and massive chronic intervillositis (MCI) are placental lesions associated with infiltration of mononuclear cells in the chorionic villi and the intervillous spaces, respectively. It is not well known whether immune cells in CVUE and MCI have similar phenotypic characteristics.
METHODS: A cross-sectional study of third trimester placentas was conducted to identify immune cell subpopulations in CVUE and MCI (n = 17/group). CVUE was diagnosed with H&E staining and antibody to CD3 in serial sections; and MCI, by the presence of massive infiltration of mononuclear cells in the intervillous spaces. Immune cells, ICAM-1 expression and nuclear factor κB (NF-κB) activation were determined immunohistochemically.
RESULTS: CVUE and MCI showed similar infiltrates, mainly CD68+ and CD3+ cells. Most cells (>80%) were CD45RB+, and one third were CD45RO+ in both lesions. There were slightly more CD8+ than CD4+ cells in both CVUE and MCI. More than 90% of cells in CVUE and MCI were ICAM-1+ with NFκB nuclear localization. Syncytiotrophoblast ICAM-1 expression was significantly (p < 0.001) higher in MCI (mean of 81.0; range of 71.6-86.0) than in CVUE (52.4; 36.4-59.4) or normal placentas (0.2; 0.0-0.6). Both, failure of physiologic transformation of spiral arteries and placental atherosclerosis-like lesions of atherosis were significantly more frequent in MCI than in CVUE or normal placentas (p = 0.044 and p = 0.007, respectively). DISCUSSION: These finding suggest that MCI and CVUE have very similar infiltration of immune cells although MCI has more severe placental lesions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosis; Failure of physiologic transformation; ICAM-1; Intervillositis; Placenta; Pregnancy; Spiral arteries; Villitis

Mesh:

Substances:

Year:  2015        PMID: 25911290     DOI: 10.1016/j.placenta.2015.03.008

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

Review 1.  The Involvement of Cell Adhesion Molecules, Tight Junctions, and Gap Junctions in Human Placentation.

Authors:  Enoch Appiah Adu-Gyamfi; Armin Czika; Philip Narteh Gorleku; Amin Ullah; Zulqarnain Panhwar; Ling-Ling Ruan; Yu-Bin Ding; Ying-Xiong Wang
Journal:  Reprod Sci       Date:  2020-11-04       Impact factor: 3.060

Review 2.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

3.  Fetal cord blood and tissue immune responses to chronic placental inflammation and chorioamnionitis.

Authors:  Anne Marie Singh; Michael G Sherenian; Kwang-Youn Kim; Kristin A Erickson; Amy Yang; Karen Mestan; Linda M Ernst; Rajesh Kumar
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-19       Impact factor: 3.406

Review 4.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

5.  Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts.

Authors:  Luca Bertero; Fulvio Borella; Paola Cassoni; Chiara Benedetto; Giovanni Botta; Andrea Carosso; Stefano Cosma; Marialuisa Bovetti; Marco Carosso; Giancarlo Abbona; Giammarco Collemi; Mauro Papotti
Journal:  Virchows Arch       Date:  2021-05-01       Impact factor: 4.064

Review 6.  The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes.

Authors:  Alexandra Bouariu; Nicolae Gică; Anca Marina Ciobanu; Ana Maria Scutelnicu; Mihaela Roxana Popescu; Anca Maria Panaitescu
Journal:  Healthcare (Basel)       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.